AGIO vs PHM · rev $65.5M vs P/E 7.7, rev $7.39B
Agios Pharm (AGIO) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
Latest reported PHM revenue for 2026-06-30 was $7.39B. Net income was $819.0M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
AGIO currently screens at market cap $1.68B. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the AGIO and PHM stock pages for the full models.
Not investment advice.